These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 23631427)
1. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones. Stössel A; Schlenk M; Hinz S; Küppers P; Heer J; Gütschow M; Müller CE J Med Chem; 2013 Jun; 56(11):4580-96. PubMed ID: 23631427 [TBL] [Abstract][Full Text] [Related]
2. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors. Brunschweiger A; Koch P; Schlenk M; Rafehi M; Radjainia H; Küppers P; Hinz S; Pineda F; Wiese M; Hockemeyer J; Heer J; Denonne F; Müller CE Bioorg Med Chem; 2016 Nov; 24(21):5462-5480. PubMed ID: 27658798 [TBL] [Abstract][Full Text] [Related]
3. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies. Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606 [TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues. Pretorius J; Malan SF; Castagnoli N; Bergh JJ; Petzer JP Bioorg Med Chem; 2008 Sep; 16(18):8676-84. PubMed ID: 18723354 [TBL] [Abstract][Full Text] [Related]
5. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. Koch P; Akkari R; Brunschweiger A; Borrmann T; Schlenk M; Küppers P; Köse M; Radjainia H; Hockemeyer J; Drabczyńska A; Kieć-Kononowicz K; Müller CE Bioorg Med Chem; 2013 Dec; 21(23):7435-52. PubMed ID: 24139167 [TBL] [Abstract][Full Text] [Related]
6. Benzothiazinones: a novel class of adenosine receptor antagonists structurally unrelated to xanthine and adenine derivatives. Gütschow M; Schlenk M; Gäb J; Paskaleva M; Alnouri MW; Scolari S; Iqbal J; Müller CE J Med Chem; 2012 Apr; 55(7):3331-41. PubMed ID: 22409573 [TBL] [Abstract][Full Text] [Related]
7. Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold. Cruz-Monteagudo M; Borges F; Cordeiro MNDS; Helguera AM; Tejera E; Paz-Y-Mino C; Sanchez-Rodriguez A; Perera-Sardina Y; Perez-Castillo Y Curr Neuropharmacol; 2017 Nov; 15(8):1117-1135. PubMed ID: 28093976 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC). Vlok N; Malan SF; Castagnoli N; Bergh JJ; Petzer JP Bioorg Med Chem; 2006 May; 14(10):3512-21. PubMed ID: 16442801 [TBL] [Abstract][Full Text] [Related]
9. The inhibition of monoamine oxidase by 2H-1,4-benzothiazin-3(4H)-ones. Hitge R; Petzer JP; Petzer A Bioorg Med Chem Lett; 2022 Dec; 77():129038. PubMed ID: 36307034 [TBL] [Abstract][Full Text] [Related]
10. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues. Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740 [TBL] [Abstract][Full Text] [Related]
11. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones. Valente S; Tomassi S; Tempera G; Saccoccio S; Agostinelli E; Mai A J Med Chem; 2011 Dec; 54(23):8228-32. PubMed ID: 22017497 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
13. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors. Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843 [TBL] [Abstract][Full Text] [Related]
14. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines. Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098 [TBL] [Abstract][Full Text] [Related]
15. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency. Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776 [TBL] [Abstract][Full Text] [Related]
16. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. Youdim MB; Gross A; Finberg JP Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700 [TBL] [Abstract][Full Text] [Related]
17. Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B. Kuder KJ; Załuski M; Schabikowski J; Latacz G; Olejarz-Maciej A; Jaśko P; Doroz-Płonka A; Brockmann A; Müller CE; Kieć-Kononowicz K ChemMedChem; 2020 May; 15(9):772-786. PubMed ID: 32162782 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
19. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors. Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]